The vitreous humor undergoes liquefaction with age, resulting in complications that may require a vitrectomy, or surgical removal of the vitreous from the eye. Silicone oil, a common vitreous substitute, lacks properties similar to the natural vitreous. In particular, it lacks antioxidants that may be necessary to reduce oxidative stress in the eye. The purpose of this study was to evaluate antioxidant-loaded hydrogel vitreous substitutes in a pilot in vivo study. Ascorbic acid and glutathione were loaded into synthesized PEGDA hydrogels. Following vitrectomy, experimental antioxidant hydrogels or silicone oil were injected into one eye of rabbits, while the other eye served as untreated or sham control. Ophthalmic assessments, including electroretinography, were performed. Levels of glutathione and ascorbic acid were higher in the eyes treated with the antioxidant-loaded hydrogel vitreous substitute, although this was not found to be significant after 28 days. There were no statistically significant differences between groups with respect to clinical examination, and ocular health scores, electroretinograms, and histology were normal. These results indicate minimal concerns for the hydrogel formulation or high levels of antioxidants. Future research will assess the capability of vitreous substitutes to prolong antioxidant release, with the goal of minimizing cataract after vitrectomy.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbm.a.37813DOI Listing

Publication Analysis

Top Keywords

hydrogel vitreous
12
vitreous substitute
12
vitreous
8
silicone oil
8
antioxidant-loaded hydrogel
8
vitreous substitutes
8
ascorbic acid
8
vivo assessment
4
assessment antioxidant
4
hydrogel
4

Similar Publications

The ability to deliver protein therapeutics in a minimally invasive, safe, and sustained manner, without resorting to viral delivery systems, will be crucial for treating a wide range of chronic injuries and diseases. Among these challenges, achieving axon regeneration and functional recovery post-injury or disease in the central nervous system remains elusive to most clinical interventions, constantly calling for innovative solutions. Here, a thermally responsive hydrogel system utilizing recombinant spider silk protein (spidroin) is developed.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examines how a monoclonal antibody (bevacizumab) interacts with silicone oils and hydrogels, revealing that exposure to silicone oils significantly decreases the antibody's functionality and causes aggregation.
  • - Results show that after 24 hours in silicone oil, bevacizumab retains only 30% of its activity, leading to concerns about its clinical use during procedures that involve silicone oil tamponade.
  • - Polysorbate, a common stabilizer, effectively reduces antibody aggregation, while hydrogels do not affect the functionality of the antibodies tested, making them a safer alternative for vitreous body replacement.
View Article and Find Full Text PDF

Intravitreal long-term sustained ranibizumab delivery using injectable microgel-embedded hydrogel.

Asian J Pharm Sci

October 2024

Department of Molecular Science and Technology, Ajou University, Suwon 16499, Republic of Korea.

Retinal vascular disease is the leading cause of visual impairment. Although intravitreal drug injections are the most suitable approach for addressing retinal disorders, existing clinical treatments necessitate repeated administration, imposing a substantial burden on patients with various intraocular complications. This study introduces an injectable and biodegradable hyaluronan microgel (Hm)-embedded gelatin-poly(ethylene glycol)-tyramine hydrogel (HmGh) designed for sustained intravitreal ranibizumab (RBZ) delivery to reduce patient burden and minimize the side effects associated with frequent injections.

View Article and Find Full Text PDF

In Vivo Assessment of an Antioxidant Hydrogel Vitreous Substitute.

J Biomed Mater Res A

January 2025

William G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, Ohio, USA.

The vitreous humor undergoes liquefaction with age, resulting in complications that may require a vitrectomy, or surgical removal of the vitreous from the eye. Silicone oil, a common vitreous substitute, lacks properties similar to the natural vitreous. In particular, it lacks antioxidants that may be necessary to reduce oxidative stress in the eye.

View Article and Find Full Text PDF

Injectable self-assembling peptide hydrogel as a promising vitreous substitute.

J Control Release

December 2024

Hunan Provincial Key Laboratory of Animal Models and Molecular Medicine, State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, School of Biomedical Sciences, Hunan University, Changsha 410082, Hunan, PR China; Greater Bay Area Institute for Innovation, Hunan University, Guangzhou 511300, Guangdong, PR China. Electronic address:

Vitreoretinal diseases pose significant threats to vision, often requiring vitrectomy and substitution of vitreous humor to restore ocular structure and visual function. However, existing substitutes have limitations that compromise patient outcomes. Supramolecular hydrogels, particularly peptide-based formulations, have emerged as promising alternatives due to their superior optical clarity, biocompatibility, and viscoelasticity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!